Browse > Article
http://dx.doi.org/10.3831/KPI.2019.22.037

Treatment of Hominis placenta pharmacopuncture for a patient with mild neurocognitive disorder: Case report  

Kim, Yunna (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Eom, Yoon Ji (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Cho, Seung-Hun (College of Korean Medicine, Kyung Hee University)
Publication Information
Journal of Pharmacopuncture / v.22, no.4, 2019 , pp. 279-283 More about this Journal
Abstract
Hominis placenta pharmacopuncture, a treatment that injects Hominis placenta extract into acupoints, has been suggested in the literature and researches that it could be used for cognitive decline. We experienced a case of mild neurocognitive disorder treated with Hominis placenta pharmacopuncture. Hominis placenta pharmacopuncture could be a possible treatment modality producing substantial clinical result in cognitive function which is assessed with Mini-Mental State Examination-Dementia Screening (MMSE-DS), Korean Version of Montreal Cognitive Assessment (MoCA-K), and Korean-Dementia Rating Scale (K-DRS). A 84-year-old man with mild neurocognitive disorder received Hominis placenta pharmacopuncture on GV20, CV12, and bilateral ST36 for a month. The results of neuropsychological examination showed increase in scores after treatment of Hominis placenta pharmacopuncture. Before treatment, they were 15 points for MoCA-K, and 120 points for K-DRS (7.6%), but after treatment, they elevated by 21 points for MoCA-K and 137 points for K-DRS (100%). MMSE-DS score was 28 points, unchanged before and after treatment. It did not cause any side-effect. Hominis placenta pharmacopuncture could be a safe option for treating mild neurocognitive disorder.
Keywords
Hominis placenta; pharmacopuncture; mild cognitive impairment; mild neurocognitive disorder;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10-29.   DOI
2 Cho KM, Keam B, Kim TM, Lee SH, Kim DW, Heo DS. Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure. Korean J Intern Med. 2015;30(6):891-8.   DOI
3 Wu T, Wang MC, Jing L, Liu ZY, Guo H, Liu Y, et al. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.Drug Des Devel Ther 2015;9:6421-31.
4 Kapp FG, Sommer A, Kiefer T, Dolken G, Haendler B. 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis. Cancer Cell Int. 2012;12(1):1.   DOI
5 Pyo JO, Nah J, Jung YK. Molecules and their functions in autophagy. Exp Mol Med. 2012;44(2):73-80   DOI
6 Mizushima N, Yoshimorim T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313-26.   DOI
7 Choi KS. Autophagy and cancer. Exp Mol Med. 2012;44(2):109-20.   DOI
8 Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Med. 2010;76(11):1118-31.   DOI
9 Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27-42.   DOI
10 Khan M, Maryam A, Zhang H, Mehmood T, Ma T. Killing cancer with platycodin D through multiple mechanisms. J Cell Mol Med 2016;20(3):389-402.   DOI
11 An BJ, Lee CE, Son JH, Lee JY, Park TS, Park JM, er al. Antioxidant, Anticancer and antibacterial Activities of Naesohwangryntang and its Ingredients, Kor J Herbology. 2005;20(4):17-26.
12 Choi EO, Park C, Hwang HJ, Hong SH, Kim GY, Cho EJ, et al. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells. Int J Oncol. 2016;49(3):1009-18.   DOI
13 Yi CH, Yuan J. The Jekyll and Hyde functions of caspases. Dev Cell. 2009;16(1):21-34.   DOI
14 Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17(25):3237-45.   DOI
15 Na PY, Chye SM, Ng ChH, Koh RY, Tiong YL, Pui LP, et al. Clinacanthus Nutans Hexane Extracts Induce Apoptosis Through a Caspase-Dependent Pathway in Human Cancer Cell Lines. Asian Pac J Cancer Prev. 2017;18(4):917-26.
16 Hua P, Sun M, Zhang G, Zhang Y, Tian X, Li X, et al. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Biochem Biophys Res Commun. 2015;460(2):136-42.   DOI
17 Macek C. East meets West to balance immunologic yin and yang. JAMA. 1984;251(4):433-5, 439.   DOI
18 Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ. 2015;22(4):526-39.   DOI
19 Vijayan V, Verstreken P. Autophagy in the presynaptic compartment in health and disease. J Cell Biol 2017;216(7):1895-1906.   DOI
20 Park C, Cha HJ, Choi EO, Lee H, Hwang-Bo H, Ji SY et al., Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells. Cancers (Basel). 2019;11(10),1494.   DOI
21 Lin SR, Fu YS, Tsai MJ, Cheng H, Weng CF. Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy. Int J Mol Sci. 2017;18(7):1412.   DOI
22 Saleh T, Cuttino L, Gewirtz DA. Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer. Biochim Biophys Acta. 2016;1860(10):2130-6.   DOI
23 Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, Walker A, et al. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy. 2017;13(8):1386-1403.   DOI
24 Fulda S. Autophagy in Cancer Therapy. Front Oncol. 2017;7:128.   DOI
25 Hooper KM, Barlow PG, Stevens C, Henderson P. Inflammatory Bowel Disease Drugs: A Focus on Autophagy. J Crohns Colitis. 2017;11(1):118-127.   DOI
26 Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev. 2011;25(19):1999-2010.   DOI
27 Lorin S, Hamai A, Mehrpour M, Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol. 2013;23(5):361-79.   DOI
28 Rosenfeldt MT, Ryan KM. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med. 2009;11:e36.   DOI
29 Graf RP, Keller N, Barbero S, Stupack D. Caspase-8 as a regulator of tumor cell motility. Curr Mol Med. 2014;14(2):246-54.   DOI
30 Wang Y, Zhang J, Huang ZH, Huang XH, Zheng WB, Yin XF, et al. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop. Cell Death Dis. 2017;8(6):e2876.   DOI
31 Yu L, Shang ZF, Hsu FM, Zhang Z, Tumati V, Lin YF, et al. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKCs inhibitor. Oncotarget. 2015;6(6):3848-60.   DOI